AI Peptide Startup Pepticom Raises $5 Million

Jerusalem-based Pepticom Ltd. has raised $5 million in a series A funding round, the company announced Thursday. Founded in 2011, Pepticom uses artificial intelligence algorithms to design peptide drug candidates based on the known structure of the required target proteins. Pepticom intends to use the investment to develop new artificial intelligence-based models of peptides.

Drugs (illustration). Photo: Shutterstock